Literature DB >> 19105658

Docking studies on a new human immunodeficiency virus integrase-Mg-DNA complex: phenyl ring exploration and synthesis of 1H-benzylindole derivatives through fluorine substitutions.

Stefania Ferro1, Laura De Luca, Maria Letizia Barreca, Nunzio Iraci, Sara De Grazia, Frauke Christ, Myriam Witvrouw, Zeger Debyser, Alba Chimirri.   

Abstract

A new model of HIV-1 integrase-Mg-DNA complex that is useful for docking experiments has been built. It was used to study the binding mode of integrase strand transfer inhibitor 1 (CHI-1043) and other fluorine analogues. Molecular modeling results prompted us to synthesize the designed derivatives which showed potent enzymatic inhibition at nanomolar concentration, high antiviral activity, and low toxicity. Microwave assisted organic synthesis (MAOS) was employed in several steps of the synthetic pathway, thus reducing reaction times and improving yields.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19105658     DOI: 10.1021/jm8009266

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Scaffold rearrangement of dihydroxypyrimidine inhibitors of HIV integrase: Docking model revisited.

Authors:  Jing Tang; Kasthuraiah Maddali; Yves Pommier; Yuk Y Sham; Zhengqiang Wang
Journal:  Bioorg Med Chem Lett       Date:  2010-04-21       Impact factor: 2.823

2.  Microwave assisted organic synthesis (MAOS) of small molecules as potential HIV-1 integrase inhibitors.

Authors:  Stefania Ferro; Sara De Grazia; Laura De Luca; Rosaria Gitto; Caterina Elisa Faliti; Zeger Debyzer; Alba Chimirri
Journal:  Molecules       Date:  2011-08-11       Impact factor: 4.411

Review 3.  Computer tools in the discovery of HIV-1 integrase inhibitors.

Authors:  Chenzhong Liao; Marc C Nicklaus
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

4.  Molecular dynamics approaches estimate the binding energy of HIV-1 integrase inhibitors and correlate with in vitro activity.

Authors:  Barry C Johnson; Mathieu Métifiot; Yves Pommier; Stephen H Hughes
Journal:  Antimicrob Agents Chemother       Date:  2011-10-28       Impact factor: 5.191

5.  Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy.

Authors:  Mark G Lewis; Sandro Norelli; Matt Collins; Maria Letizia Barreca; Nunzio Iraci; Barbara Chirullo; Jake Yalley-Ogunro; Jack Greenhouse; Fausto Titti; Enrico Garaci; Andrea Savarino
Journal:  Retrovirology       Date:  2010-03-16       Impact factor: 4.602

Review 6.  Piecing together the structure of retroviral integrase, an important target in AIDS therapy.

Authors:  Mariusz Jaskolski; Jerry N Alexandratos; Grzegorz Bujacz; Alexander Wlodawer
Journal:  FEBS J       Date:  2009-04-14       Impact factor: 5.542

Review 7.  Therapeutic strategies underpinning the development of novel techniques for the treatment of HIV infection.

Authors:  Jian J Tan; Xiao J Cong; Li M Hu; Cun X Wang; Lee Jia; Xing-Jie Liang
Journal:  Drug Discov Today       Date:  2010-01-22       Impact factor: 7.851

8.  A dynamic model of HIV integrase inhibition and drug resistance.

Authors:  Alex L Perryman; Stefano Forli; Garrett M Morris; Catherine Burt; Yuhui Cheng; Michael J Palmer; Kevin Whitby; J Andrew McCammon; Chris Phillips; Arthur J Olson
Journal:  J Mol Biol       Date:  2010-01-22       Impact factor: 5.469

9.  Examination of halogen substituent effects on HIV-1 integrase inhibitors derived from 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-ones and 4,5-dihydroxy-1H-isoindole-1,3(2H)-diones.

Authors:  Xue Zhi Zhao; Kasthuraiah Maddali; B Christie Vu; Christophe Marchand; Stephen H Hughes; Yves Pommier; Terrence R Burke
Journal:  Bioorg Med Chem Lett       Date:  2009-03-28       Impact factor: 2.823

10.  Diketoacid-genre HIV-1 integrase inhibitors containing enantiomeric arylamide functionality.

Authors:  Xue Zhi Zhao; Kasthuraiah Maddali; Christophe Marchand; Yves Pommier; Terrence R Burke
Journal:  Bioorg Med Chem       Date:  2009-05-08       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.